Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eli Lilly and

    NYSE: LLY · Real-Time Price · USD
    704.83
    20.40 (2.98%)
    At close: Aug 15, 2025, 3:02 PM

    Eli Lilly and Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 53.26B 49B 45.04B 40.86B 38.92B 35.93B 34.12B 32.07B 29.52B 27.69B 28.54B 29.24B 29.07B 29.32B 28.32B 27.76B 26.73B 25.49B
    Cost of Revenue
    		 9.25B 8.97B 8.42B 7.8B 7.49B 7.13B 7.08B 6.84B 6.56B 6.18B 6.63B 7.13B 6.98B 7.51B 7.31B 6.98B 6.88B 6.15B
    Gross Profit
    		 44.13B 40.03B 36.62B 33.06B 31.43B 28.8B 27.04B 25.23B 22.95B 21.51B 21.91B 22.11B 22.09B 21.82B 21.01B 20.78B 19.85B 19.34B
    Operating Income
    		 22.78B 20.17B 17.5B 14.9B 13.89B 11.81B 10.79B 9.8B 8.3B 7.7B 8.65B 8.92B 9.01B 8.78B 7.87B 7.79B 7.15B 7.11B
    Interest Income
    		 180.4M 177.7M 175.2M 175.4M 176.5M 185.2M 173.6M 154.6M 125.8M 90M 62.8M 44.7M 31.6M 26.8M 25.3M 23.7M 22.5M 24.2M
    Pretax Income
    		 16.86B 13.6B 12.68B 10.15B 8.99B 7.56B 6.55B 6.14B 7.28B 6.28B 6.81B 6.55B 6.23B 6.73B 6.16B 6.78B 6.98B 7.03B
    Net Income
    		 13.8B 11.11B 10.59B 8.37B 7.34B 6.14B 5.24B 4.99B 6.5B 5.69B 6.24B 6.03B 5.69B 6.13B 5.58B 5.97B 6.07B 6.09B
    Selling & General & Admin
    		 9.41B 8.66B 8.13B 7.63B 7.34B 7.14B 6.94B 6.68B 6.52B 6.24B 6.07B 6.04B 6.02B 6.1B 6.14B 6.12B 6.07B 5.87B
    Research & Development
    		 11.83B 11.2B 10.99B 10.53B 10.21B 9.85B 9.31B 8.75B 8.14B 7.57B 7.19B 7.15B 7.06B 6.93B 6.99B 6.87B 6.63B 6.37B
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 21.23B 19.86B 19.12B 18.16B 17.54B 17B 16.25B 15.43B 14.66B 13.8B 13.26B 13.19B 13.08B 13.03B 13.13B 12.99B 12.7B 12.23B
    Interest Expense
    		 910.1M 844.7M 780.6M 694.1M 626M 562.7M 485.9M 431.7M 388.6M 349.5M 331.6M 329M 331.1M 336.8M 339.7M 347.5M 353.5M 354.9M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 30.48B 28.83B 27.54B 25.97B 25.03B 24.12B 23.34B 22.27B 21.22B 19.99B 19.89B 20.32B 20.06B 20.54B 20.45B 19.97B 19.58B 18.38B
    Income Tax Expense
    		 3.06B 2.49B 2.09B 1.78B 1.65B 1.42B 1.31B 1.15B 783M 595.7M 561.6M 516.7M 538.1M 603.4M 573.8M 812.3M 905.9M 933.9M
    Shares Outstanding (Basic)
    		 897.9M 897.99M 897.54M 901M 900.9M 900.8M 899.38M 949.3M 949.29M 949.27M 950.18M 900.7M 900.3M 950.61M 953.65M 956.59M 907.3M 959.48M
    Shares Outstanding (Diluted)
    		 899.79M 900.6M 903.16M 905M 904.2M 903.8M 903.98M 949.3M 949.29M 949.27M 950.18M 903.8M 902.9M 950.61M 953.65M 956.59M 910.4M 959.48M
    EPS (Basic)
    		 15.36 12.35 11.77 9.29 8.15 6.72 5.65 5.26 6.93 6.13 6.71 6.48 6.03 6.50 5.91 6.31 6.41 6.36
    EPS (Diluted)
    		 15.30 12.29 11.71 9.25 8.12 6.70 5.64 5.26 6.93 6.12 6.70 6.47 6.02 6.50 5.91 6.31 6.41 6.36
    EBITDA
    		 19.66B 16.27B 15.23B 12.51B 11.23B 9.69B 8.57B 8.09B 9.14B 8.08B 8.66B 8.47B 8.17B 8.7B 8.04B 8.6B 8.78B 8.78B
    EBIT
    		 17.77B 14.45B 13.46B 10.84B 9.62B 8.12B 7.04B 6.57B 7.67B 6.63B 7.14B 6.88B 6.56B 7.07B 6.5B 7.13B 7.33B 7.38B
    Depreciation & Amortization
    		 1.89B 1.83B 1.77B 1.67B 1.61B 1.57B 1.53B 1.51B 1.47B 1.45B 1.52B 1.59B 1.61B 1.63B 1.55B 1.47B 1.45B 1.4B

    Add to Watchlist